Latest Human papillomavirus Stories

PLEASANTON, Calif., Feb. 1, 2012 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance to the cobas® CT/NG Test for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections in both symptomatic and asymptomatic patients from male urine and self -collected vaginal swabs. A polymerase chain reaction (PCR)-based multiplex dual probe assay, the test for chlamydia...

According to a new study, oral infections with the human papillomavirus (HPV) are more common in men than women. The study, published in the Journal of the American Medical Association, said that while the viruses can be found in saliva, HPV appears to be mostly spread through sex. Study author Maura Gillison, a professor at the Ohio State University Comprehensive Cancer Center said the virus can cause cancers at the back of the throat, tonsils and base of the tongue.  Patients...

Research physicians from Georgetown Lombardi Comprehensive Cancer Center will present new data about a complex group of cancers known as head and neck cancers at the Multidisciplinary Head and Neck Cancer Symposium, January 26 through 28, in Phoenix, Arizona. Should patients with HPV+ head and neck cancers receive less chemotherapy? Georgetown researchers are examining a hypothesis about whether HPV+ patients with a head and neck cancer should receive more or less chemotherapy....

Oral HPV infection is more common among men than women, explaining why men are more prone than women to develop an HPV related head and neck cancer, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM. Human papillomavirus, or HPV, has recently been linked to some types of head and neck cancer that are becoming more prominent in the United States, mostly among men. Patients infected with oral HPV type 16 have a 14...

The overall prevalence of oral human papillomavirus (HPV) infection is approximately 7 percent among men and women ages 14 to 69 years in the United States, while the prevalence among men is higher than among women, according to a study appearing in JAMA. The study is being released early online to coincide with its presentation at the Multidisciplinary Head and Neck Cancer Symposium. "Oral HPV infection is the cause of a subset of oropharyngeal [relating to the mouth and pharynx] squamous...

2-year study tracked results for 190,000 girls and women Gardasil, the human papillomavirus vaccine that is now recommended for male and female adolescents and young adults, does not trigger autoimmune conditions such as lupus, rheumatoid arthritis, type 1 diabetes or multiple sclerosis after vaccination in young women, according to a new study in the Journal of Internal Medicine. Kaiser Permanente researchers used electronic health records to conduct an observational safety study of...

Precursors of cervical cancer can be detected and treated earlier / Risk of over-treatment Studies currently available provide indications and a "hint” that precursors of cervical cancer can be detected and treated earlier, and consequently tumors occur less often, in women who underwent testing for human papillomavirus (HPV). In this context, an HPV test can be used alone or in addition to a Papanicolaou test (Pap smear). However, both screening procedures also carry a risk of harm in...

VyGone Inhibitor Zapper brings quick, effective relief for genital warts, cold sores, herpes and other uncomfortable and embarrassing conditions before they ever appear. Springville, UT (PRWEB) January 23, 2012 With almost 6 million people contracting new cases of genital warts each year in the US, there has been a growing demand for faster, more effective genital warts treatment. Finally, the solution is here. The VyGone Inhibitor Zapper uses electro waveform technology to treat the...

Human papillomavirus (HPV) testing of self-collected specimens may be a more effective way to screen for cervical cancer in low-resource settings compared to visual inspection with acetic acid (VIA) and liquid-based cytology (LBC), according to a study published January 23 in the Journal of the National Cancer Institute. Cervical cancer is the third most common cancer found in women with approximately 530,000 new cases each year resulting in an estimated 275,000 deaths. In developed...

LONDON, January 23, 2012 /PRNewswire/ -- Roche sets up co -marketing agreement with private laboratory to support greater access to HPV testing In an innovative commercial agreement, leading healthcare company Roche and foremost private cellular pathology laboratory Unilabs-IHS, are collaborating to help make state-of-the art testing for signs of cervical cancer more accessible to thousands of women in London and throughout the UK. Roche's leading-edge and fully...